Becton, Dickinson and Company (BDX) Increases Dividend to $0.75 Per Share
Becton, Dickinson and Company (NYSE:BDX) announced a quarterly dividend on Monday, November 20th, RTT News reports. Investors of record on Friday, December 8th will be given a dividend of 0.75 per share by the medical instruments supplier on Friday, December 29th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. This is a positive change from Becton, Dickinson and’s previous quarterly dividend of $0.73.
Becton, Dickinson and has increased its dividend payment by an average of 10.1% per year over the last three years and has increased its dividend annually for the last 45 consecutive years. Becton, Dickinson and has a payout ratio of 27.5% indicating that its dividend is sufficiently covered by earnings. Analysts expect Becton, Dickinson and to earn $11.79 per share next year, which means the company should continue to be able to cover its $2.92 annual dividend with an expected future payout ratio of 24.8%.
Becton, Dickinson and (BDX) traded up $1.19 on Monday, hitting $221.50. 807,948 shares of the company were exchanged, compared to its average volume of 1,322,965. The company has a debt-to-equity ratio of 1.48, a quick ratio of 5.01 and a current ratio of 5.56. Becton, Dickinson and has a 1-year low of $161.29 and a 1-year high of $225.23. The company has a market cap of $50,130.00, a PE ratio of 23.22, a P/E/G ratio of 1.73 and a beta of 1.04.
Becton, Dickinson and (NYSE:BDX) last released its quarterly earnings data on Thursday, November 2nd. The medical instruments supplier reported $2.40 EPS for the quarter, beating the Zacks’ consensus estimate of $2.37 by $0.03. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.14 billion. During the same quarter in the prior year, the company earned $2.12 EPS. The firm’s quarterly revenue was down 2.0% on a year-over-year basis. research analysts predict that Becton, Dickinson and will post 10.63 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/11/20/becton-dickinson-and-company-bdx-increases-dividend-to-0-75-per-share.html.
In related news, insider Gary M. Cohen sold 15,044 shares of the firm’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $200.43, for a total value of $3,015,268.92. Following the completion of the sale, the insider now directly owns 95,270 shares in the company, valued at approximately $19,094,966.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary M. Cohen sold 15,512 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the completion of the sale, the insider now owns 95,781 shares of the company’s stock, valued at $19,517,294.37. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 47,038 shares of company stock valued at $9,480,225. Company insiders own 1.40% of the company’s stock.
A number of equities analysts have issued reports on the company. BidaskClub upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating in a report on Monday, August 14th. Royal Bank Of Canada reiterated a “hold” rating and set a $210.00 target price on shares of Becton, Dickinson and in a report on Wednesday, October 25th. Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $234.00 target price for the company in a report on Tuesday, October 31st. Cowen and Company reiterated a “buy” rating and set a $230.00 target price on shares of Becton, Dickinson and in a report on Monday, August 14th. Finally, Barclays PLC reiterated an “equal weight” rating and set a $210.00 target price (up previously from $205.00) on shares of Becton, Dickinson and in a report on Thursday, August 10th. Five investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Becton, Dickinson and presently has an average rating of “Buy” and a consensus target price of $214.79.
About Becton, Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.
Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.